<p>a, data from ECOG PS 1–2; b, data from ECOG PS 0–1;</p><p>ECOG PS, Eastern Cooperative Oncology Group performance status; BCLC, Barcelona Clinic Liver Cancer; MVI, macroscopic vascular invasion; EHS, extrahepatic spread; HBV, hepatitis B virus; HCV, hepatitis C virus.</p><p>Baseline characteristics of patients in the trials included in the meta-analysis.</p
<p>Baseline demographic data and patient characteristics at the time of being diagnosed with interme...
<p>Treatment group = HBsAg-negative patients with HCC undergoing anti-cancer therapy (n = 109).</p><...
<p>CMV, cytomegalovirus; BMI, body mass index; MELD, model for end-stage liver disease; DDLT, deceas...
<p>ECOG PS: Eastern Cooperative Oncology Group performance status.</p><p>Main baseline characteristi...
<p>Abbreviations: HCC, hepatocellular carcinoma; AJCC, American Joint Committee on Cancer; Anti-HCV ...
<p>Baseline characteristics of patients with hepatocellular carcinoma by type of treatment, 2007–201...
<p>Baseline characteristics of HCV-infected patients and healthy individuals.</p
<p>TACE, transarterial chemoembolization; BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B viru...
<p>Baseline characteristics of the 72 PPGL patients according to the occurrence of metastasis.</p
<p>Epidemiological and clinical characteristics of HCV-infected patients at baseline.</p
<p>TACE, transartialchemoembolization; LC, liver cirrhosis; OS, overall survival; TTP, time to progr...
<p>HAART: Highly active antiretroviral therapy; HCV: Hepatitis C virus.</p>*<p>Available for 98 subj...
<p>Abbreviations: Allo - allogeneic hematopoietic stem cell transplant; Auto-autologous hematopoieti...
<p><sup>†</sup>non-HBV, non-HCV and non-alcoholic.</p><p><sup>‡</sup>MELD scores: < 13 set to 13.</p...
<p>Baseline clinical characteristics of the study patients with baseline HBV DNA ≥ 2000 IU /mL.</p
<p>Baseline demographic data and patient characteristics at the time of being diagnosed with interme...
<p>Treatment group = HBsAg-negative patients with HCC undergoing anti-cancer therapy (n = 109).</p><...
<p>CMV, cytomegalovirus; BMI, body mass index; MELD, model for end-stage liver disease; DDLT, deceas...
<p>ECOG PS: Eastern Cooperative Oncology Group performance status.</p><p>Main baseline characteristi...
<p>Abbreviations: HCC, hepatocellular carcinoma; AJCC, American Joint Committee on Cancer; Anti-HCV ...
<p>Baseline characteristics of patients with hepatocellular carcinoma by type of treatment, 2007–201...
<p>Baseline characteristics of HCV-infected patients and healthy individuals.</p
<p>TACE, transarterial chemoembolization; BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B viru...
<p>Baseline characteristics of the 72 PPGL patients according to the occurrence of metastasis.</p
<p>Epidemiological and clinical characteristics of HCV-infected patients at baseline.</p
<p>TACE, transartialchemoembolization; LC, liver cirrhosis; OS, overall survival; TTP, time to progr...
<p>HAART: Highly active antiretroviral therapy; HCV: Hepatitis C virus.</p>*<p>Available for 98 subj...
<p>Abbreviations: Allo - allogeneic hematopoietic stem cell transplant; Auto-autologous hematopoieti...
<p><sup>†</sup>non-HBV, non-HCV and non-alcoholic.</p><p><sup>‡</sup>MELD scores: < 13 set to 13.</p...
<p>Baseline clinical characteristics of the study patients with baseline HBV DNA ≥ 2000 IU /mL.</p
<p>Baseline demographic data and patient characteristics at the time of being diagnosed with interme...
<p>Treatment group = HBsAg-negative patients with HCC undergoing anti-cancer therapy (n = 109).</p><...
<p>CMV, cytomegalovirus; BMI, body mass index; MELD, model for end-stage liver disease; DDLT, deceas...